Sandrine Marlin

Title: Sandrine Marlin: Innovator in Genetic Research

Introduction

Sandrine Marlin is a prominent inventor based in La Garenne Colombes, France. She has made significant contributions to the field of genetics, particularly in understanding prelingual non-syndromic deafness. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Marlin's latest patents focus on mutations within the connexin 26 gene, which are responsible for prelingual non-syndromic deafness. One of her patents describes a purified polynucleotide that has a chain of nucleotides corresponding to a mutated sequence. This sequence, in its wild form, encodes a polypeptide implicated in hereditary sensory defects. The mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness, specifically a deletion of at least one nucleotide.

Career Highlights

Sandrine Marlin is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to the field of microbiology and immunology. Her work at this institution has allowed her to explore genetic mutations and their implications in human health.

Collaborations

Marlin has collaborated with notable scientists in her field, including Christine Petit and Francoise Denoyelle-Gryson. These collaborations have furthered her research and contributed to advancements in understanding genetic disorders.

Conclusion

Sandrine Marlin's innovative work in genetic research highlights her dedication to understanding and addressing hereditary sensory defects. Her contributions through patents and collaborations continue to impact the scientific community positively.